These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36016606)

  • 21. Exploring the nucleotide molecular mechanism of compound kushen injection for lung adenocarcinoma based on network pharmacology and molecular docking.
    Ye Z; Yao X; Chen Z; Jin Q; You Q
    Front Oncol; 2022; 12():1013052. PubMed ID: 36419898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of Compound Kushen Injection and cisplatin shows synergistic antitumor activity in p53-R273H/P309S mutant colorectal cancer cells through inducing apoptosis.
    Wu X; Lu Y; Qin X
    J Ethnopharmacol; 2022 Jan; 283():114690. PubMed ID: 34597653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell cycle arrest is an important mechanism of action of compound Kushen injection in the prevention of colorectal cancer.
    Sun J; Li M; Lin T; Wang D; Chen J; Zhang Y; Mu Q; Su H; Wu N; Liu A; Yu Y; Liu Y; Wang S; Yu X; Guo J; Yu W
    Sci Rep; 2022 Mar; 12(1):4384. PubMed ID: 35288618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrated bioinformatics analysis to decipher molecular mechanism of compound Kushen injection for esophageal cancer by combining WGCNA with network pharmacology.
    Zhou W; Wu J; Zhang J; Liu X; Guo S; Jia S; Zhang X; Zhu Y; Wang M
    Sci Rep; 2020 Jul; 10(1):12745. PubMed ID: 32728182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uncovering the anticancer mechanism of Compound Kushen Injection against HCC by integrating quantitative analysis, network analysis and experimental validation.
    Gao L; Wang KX; Zhou YZ; Fang JS; Qin XM; Du GH
    Sci Rep; 2018 Jan; 8(1):624. PubMed ID: 29330507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anti-tumor and analgesic activity evaluation and mechanism of Compound Kushen Injection].
    Fan QQ; She GM; Wei J; Li ZQ; Chen ML; Dong Y; Yu AX; Li JW; Qin WJ; Wang W; Lin RC; Zhao CJ; You RL
    Zhongguo Zhong Yao Za Zhi; 2022 May; 47(10):2712-2720. PubMed ID: 35718491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compound Kushen Injection intervenes metabolic reprogramming and epithelial-mesenchymal transition of HCC via regulating β-catenin/c-Myc signaling.
    Wang KX; Du GH; Qin XM; Gao L
    Phytomedicine; 2021 Dec; 93():153781. PubMed ID: 34649212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection With Transcriptome Analysis.
    Shen H; Qu Z; Harata-Lee Y; Aung TN; Cui J; Wang W; Kortschak RD; Adelson DL
    Front Oncol; 2019; 9():632. PubMed ID: 31380274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Compound Kushen Injection, a Natural Compound Mixture, and Its Identified Chemical Components on Migration and Invasion of Colon, Brain, and Breast Cancer Cell Lines.
    Nourmohammadi S; Aung TN; Cui J; Pei JV; De Ieso ML; Harata-Lee Y; Qu Z; Adelson DL; Yool AJ
    Front Oncol; 2019; 9():314. PubMed ID: 31106149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High Throughput Transcriptome Data Analysis and Computational Verification Reveal Immunotherapy Biomarkers of Compound Kushen Injection for Treating Triple-Negative Breast Cancer.
    Liu X; Wu Y; Zhang Y; Bu D; Wu C; Lu S; Huang Z; Song Y; Zhao Y; Guo F; Ye P; Fu C; Shen L; Zhang J; Wang H; Duan X; Wu J
    Front Oncol; 2021; 11():747300. PubMed ID: 34604090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
    Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
    J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of Compound Kushen Injection for the Treatment of Lung Cancer Based on Network Pharmacology.
    Meng Z; Liu X; Wu J; Zhou W; Wang K; Jing Z; Liu S; Ni M; Zhang X
    Evid Based Complement Alternat Med; 2019; 2019():4637839. PubMed ID: 31275410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fractional Deletion of Compound Kushen Injection Indicates Cytokine Signaling Pathways are Critical for its Perturbation of the Cell Cycle.
    Aung TN; Nourmohammadi S; Qu Z; Harata-Lee Y; Cui J; Shen HY; Yool AJ; Pukala T; Du H; Kortschak RD; Wei W; Adelson DL
    Sci Rep; 2019 Oct; 9(1):14200. PubMed ID: 31578346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of compound kushen injection on cancer cells: Integrated identification of candidate molecular mechanisms.
    Cui J; Qu Z; Harata-Lee Y; Shen H; Aung TN; Wang W; Kortschak RD; Adelson DL
    PLoS One; 2020; 15(7):e0236395. PubMed ID: 32730293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compound kushen injection suppresses human acute myeloid leukaemia by regulating the Prdxs/ROS/Trx1 signalling pathway.
    Jin Y; Yang Q; Liang L; Ding L; Liang Y; Zhang D; Wu B; Yang T; Liu H; Huang T; Shen H; Tu H; Pan Y; Wei Y; Yang Y; Zhou F
    J Exp Clin Cancer Res; 2018 Nov; 37(1):277. PubMed ID: 30454068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compound Kushen Injection Induces Immediate Hypersensitivity Reaction Through Promoting the Production of Platelet-Activating Factor via
    Gao Y; Hai L; Kang Y; Qin W; Liu F; Cai R; Yang X; Qi Y
    Front Pharmacol; 2021; 12():768643. PubMed ID: 34690789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A network pharmacology-based approach to explore the active ingredients and molecular mechanism of Lei-gong-gen formula granule on a spontaneously hypertensive rat model.
    Li Q; Lan T; He S; Chen W; Li X; Zhang W; Liu Y; Zhang Q; Chen X; Han Y; Su Z; Zhu D; Guo H
    Chin Med; 2021 Oct; 16(1):99. PubMed ID: 34627325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Identification of potential targets and synergistic mechanism of Kushen Decoction for the treatment of cryptosporidiosis].
    Zhan N; Liu XH; Tang FY; Zhang JY
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2021 Oct; 33(5):483-495. PubMed ID: 34791846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Compound Kushen Injection Protects Skin From Radiation Injury
    Zheng J; Li G; Wang J; Wang S; Tang Q; Sheng H; Wu W; Wang S
    Front Pharmacol; 2021; 12():753068. PubMed ID: 34955827
    [No Abstract]   [Full Text] [Related]  

  • 40. Anhydroicaritin Inhibits EMT in Breast Cancer by Enhancing GPX1 Expression: A Research Based on Sequencing Technologies and Bioinformatics Analysis.
    Li F; Shi Y; Yang X; Luo Z; Zhang G; Yu K; Li F; Chen L; Zhao Y; Xie Y; Wu Y; Yang J; Zhou X; Liu S
    Front Cell Dev Biol; 2021; 9():764481. PubMed ID: 35178395
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.